Our virus-based particles, which were pseudotyped with the VSV-G envelope protein, could be combined with novel envelope-based pseudotyping strategies, such as those from measles or Nipah viruses, to allow cell-specific targeting of the particles to various cell types in vitro and in vivo.37 This evidence concerns the gene ERVW-1 and measles.